Abstract
SARS-CoV-2 is the pathogenic agent of COVID-19, a disease responsible for more than 5 million deaths in the world until the moment, with more than 360 million cases reported. An essential clinical aspect observed in patients with the disease is the more significant risk of complications associated with obesity cases. It has already been described that SARS-CoV-2 could infect the adipose t…